Mode
Text Size
Log in / Sign up

Early time-restricted eating and bright light therapy protocol for insulin-independent type 2 diabetesNew Trial to Test Diet and Light Therapy for Diabetes

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that this is a trial protocol; no results are available to inform clinical practice at this time.

This randomized controlled trial protocol outlines a study involving 344 adults with insulin-independent type 2 diabetes. The study aims to evaluate the impact of lifestyle interventions on glycemic control and circadian rhythms.

The intervention includes early time-restricted eating (eTRE), where participants eat within an 8-hour window ending by 17:00, and/or daytime bright light therapy (BLT). BLT involves 90 min/day before 15:00 using blue-light-blocking glasses and blackout curtains at night. The control group comparison is planned for the study.

Primary outcomes include glycemic control measured by HbA1c and 24-hour glucose. Secondary outcomes include diurnal melatonin rhythms, diurnal cortisol rhythms, and diurnal variation in glucose uptake. The study includes a 16 weeks intensive phase with a follow-up at the 1-year mark.

No results, safety data, or tolerability metrics are reported because the study is currently in the protocol phase. Clinical application is not yet possible as the trial has not been conducted.

How this fits prior evidence

How this fits prior evidence: This protocol addresses a gap in non-pharmacological management for type 2 diabetes. While prior coverage noted that tirzepatide reduces MACE in adults with type 2 diabetes and obesity (OR 0.87), and that high-risk adiposity and inflammation trajectories correlate with increased risk of incident type 2 diabetes, this study explores the role of eTRE and BLT. It also addresses the need for long-term follow-up, which was noted as a gap in multicomponent discharge planning for diabetes.

Researchers have published a plan for a new clinical trial that will test two lifestyle changes for people with type 2 diabetes who do not need insulin. The trial will include 344 adults. They will be asked to eat all their meals within an 8-hour window that ends by 5 p.m. (called early time-restricted eating). Some will also receive bright light therapy for 90 minutes each day before 3 p.m., and they will wear blue-light-blocking glasses and use blackout curtains at night to improve their sleep and body rhythms.

The main goal is to see if these changes improve blood sugar control, measured by HbA1c and 24-hour glucose levels. The researchers will also look at daily rhythms of melatonin and cortisol, and how glucose uptake changes throughout the day. The intensive part of the study lasts 16 weeks, and participants will be checked again one year later.

This is a protocol, meaning the study has not been done yet. No results are available, so we don't know if these approaches will work. The trial is designed to find out if they do.

For now, this news is about a planned study, not a proven treatment. People with type 2 diabetes should continue to follow their doctor's advice and not change their eating or light exposure based on this protocol alone.

What this means for you:
A new trial will test if early eating and bright light therapy improve blood sugar, but results are not yet available.

Common questions

What is this study about?

This is a plan for a clinical trial that will test two lifestyle changes for people with type 2 diabetes who don't need insulin. The changes are early time-restricted eating (eating within an 8-hour window ending by 5 p.m.) and daytime bright light therapy (90 minutes a day before 3 p.m.). The goal is to see if these improve blood sugar control.

Who can participate in this trial?

The trial plans to include 344 adults with type 2 diabetes who do not need insulin. The study is not yet underway, so it's not open for enrollment yet. If you're interested, you should talk to your doctor about whether this type of approach might be right for you, and keep an eye out for when the trial starts.

What are the possible risks or side effects?

The study protocol does not report any side effects or safety concerns yet. Since this is just a plan, we don't have information on adverse events. Any changes to eating or light exposure should be discussed with a healthcare provider, especially if you have diabetes or other health conditions.

Study Details

Study typeRct
EvidenceLevel 2
Follow-up3.7 mo
PublishedSep 2026
View Original Abstract ↓
Disruption of circadian rhythms worsens glycemic control and cardiovascular health. Conversely, evidence suggests that optimizing circadian rhythms by eating earlier in the day, practicing intermittent fasting, and/or getting sufficient sunlight or bright light during the daytime improves cardiometabolic health. Here, we describe the protocol for a 2 × 2 randomized controlled trial testing whether two chronotherapies-early time-restricted eating (eTRE) and/or daytime bright light therapy (BLT)-can improve glycemic control, diurnal rhythms, and overall health in adults with type 2 diabetes (T2D). We will randomize 344 adults with insulin-independent T2D to 1 of 4 groups: (1) control, (2) eTRE, (3) daytime BLT, or (4) eTRE + daytime BLT. Participants in the eTRE groups will eat within an 8-hour window ending by 17:00, while those in the BLT group will receive bright light for 90 min/day before 15:00 and use blue-light-blocking glasses and blackout curtains at night. The intensive phase of the intervention is 16 weeks, with follow-up at the 1-year mark. The primary outcome is glycemic control as measured by HbA1c and 24-hour glucose, supplemented by additional assessments of glucose metabolism. Secondary outcomes are the diurnal melatonin and cortisol rhythms and the diurnal variation in glucose uptake. Tertiary outcomes include body mass, body composition, resting energy expenditure, cardiovascular risk factors, sleep parameters, quality of life, and psychological health. To our knowledge, this is the largest study to date of TRE in people with T2D and the largest study to test whether daytime bright light therapy can improve cardiometabolic health. Trial Registration: This trial was registered at clinicaltrials.gov (NCT04155619).
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.